Towards a more Agile Vendor Qualification: A Discussion with Dele Babalola and Rani Naik

Transformation in Trials

Ever wondered why the life sciences industry is stuck in redundant vendor qualification processes? Picture an organization where quality is designed rather than inspected. Yes, it's possible and we're about to paint that picture for you in this stimulating conversation with our guests, Dele Babalola and Rani Naik. They've got their fingers on the pulse of the GxP space and are ready to share their insights on the pressing need to evolve from redundant processes. Pay attention as Rani unfolds her unique vision for an agile, phase-appropriate quality organization.
Imagine a world where vendor qualification is not a daunting task but a streamlined process. We got you thinking, right? Dele and Rani join us to unravel this concept further. It's all about being proactive, focusing on effective oversight, and perhaps venturing into the world of pre-approved vendors. From discussing the role of certification bodies to emphasizing the significance of a proactive approach, we've got this topic well covered.
Enter the world of vendor management where challenges are like a complex puzzle waiting to be solved. This is where Dele and Rani's expertise shines as they shed light on transparency, collaboration, and the risk-based approach. Here's a plus - they also detail the potential value of remote audits and the importance of having an internal individual who can ensure clear process flow. As we wrap up, we can't help but yearn for a more innovative industry that's ready to take leaps. You won't want to miss this candid conversation.

________
Reach out to Sam Parnell and Ivanna Rosendal
Join the conversation on our LinkedIn page

Bab

1. Towards a more Agile Vendor Qualification: A Discussion with Dele Babalola and Rani Naik (00:00:00)

2. Improving Efficiency in Vendor Qualification (00:00:21)

3. Improving Vendor Oversight and Qualification Processes (00:15:42)

4. Challenges and Considerations in Vendor Management (00:29:31)

5. Challenges in the Life Sciences Industry (00:43:43)